CN110693984A - Traditional Chinese medicine composition for treating lumbar intervertebral disc protrusion - Google Patents
Traditional Chinese medicine composition for treating lumbar intervertebral disc protrusion Download PDFInfo
- Publication number
- CN110693984A CN110693984A CN201911217844.0A CN201911217844A CN110693984A CN 110693984 A CN110693984 A CN 110693984A CN 201911217844 A CN201911217844 A CN 201911217844A CN 110693984 A CN110693984 A CN 110693984A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- traditional chinese
- medicine composition
- intervertebral disc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/17—Gnetophyta, e.g. Ephedraceae (Mormon-tea family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/237—Notopterygium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/238—Saposhnikovia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/56—Loganiaceae (Logania family), e.g. trumpetflower or pinkroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/732—Chaenomeles, e.g. flowering quince
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Inorganic Chemistry (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine composition for treating lumbar intervertebral disc protrusion, which comprises the following components in parts by weight: 5-50 parts of ephedra, 3-10 parts of achyranthes, 3-10 parts of obscured homalomena rhizome, 3-10 parts of anisetree, 3-10 parts of pawpaw, 3-20 parts of frankincense, 3-20 parts of myrrh, 3-10 parts of divaricate saposhnikovia root, 3-10 parts of notopterygium root, 3-10 parts of eucommia charcoal, 3-20 parts of native copper, 3-10 parts of safflower, 3-10 parts of liquorice, 3-10 parts of cassia twig, 3-10 parts of Dahuo and 5-50 parts of prepared nux vomica. The Chinese medicinal composition has the effects of warming kidney, tonifying yang, nourishing marrow and strengthening bones; breaking accumulation and dissipating blood stasis, and dispelling cold and removing dampness; relieving swelling, resolving hard mass, setting bone and stretching muscle; dredging meridian passage, strengthening waist and relieving pain. The clinical treatment of lumbar disc herniation, protrusion, prolapse and sciatica has obvious curative effect.
Description
Technical Field
The invention relates to the technical field of traditional Chinese medicines, in particular to a traditional Chinese medicine composition for treating lumbar disc herniation.
Background
Clinical statistics show that the prolapse of lumbar intervertebral disc is one of the most common diseases in orthopedics outpatient service and is also the most common cause of lumbocrural pain. Going back to history, the appearance of the intervertebral disc was described by Vesalius as early as 1543. In the 20 th century, Shmorl in Germany published 11 papers on the anatomy and pathology of intervertebral discs and made extensive studies on intervertebral discs. In 1932 Barr first suggested that lumbar disc herniation was a possible cause of pain in the lower back and legs. Thereafter, Barr and Mixter first proposed concepts and treatments relating to lumbar disc herniation. Since then, the basic research on the prolapse of lumbar intervertebral disc has been advanced, and the clinical diagnosis and treatment effects of the prolapse of lumbar intervertebral disc have been further improved.
Clinical symptoms of lumbar disc herniation: the clinical symptoms differ greatly according to the position and size of the herniated (herniated) nucleus pulposus and the sagittal diameter of the vertebral canal, pathological characteristics, body state, individual sensitivity and the like. Therefore, the understanding and determination of the symptoms of the disease must be comprehensively understood and inferred from the point of view of pathophysiology and pathoanatomy. The common symptoms of this disease are now described:
1. lumbago: more than 95% of patients with prolapse of lumbar intervertebral disc have the symptoms, including those of vertebral body type.
2. Lower limb radiating pain: this disease occurs in more than 80% of cases, with the latter reaching more than 95%.
3. Numbness of limbs: the former is usually accompanied by numbness and no pain, which is only about 5%. This is primarily due to stimulation of proprioceptive and tactile fibers within the spinal nerve root. The range and the position of the nerve root sequence are determined by the number of the affected nerve root sequences.
4. Cold sensation of limbs: in a few cases (about 5% -10%), the limbs are consciously cold and cool, mainly due to stimulation of sympathetic nerve fibers in the spinal canal. The skin temperature of the affected limb is lower: like cold sensation of limbs, sympathetic vasoconstriction is also reflexively caused by pain in the affected limb. Or the stimulation of paraspinal sympathetic nerve fibers can cause sciatica and lower skin temperature of the lower leg and toes, especially the toes. This decrease in skin temperature is more pronounced in sacral 1 nerve root compression than in lumbar 5 nerve root compression.
5. Intermittent claudication: the generation mechanism and clinical manifestations are similar to those of lumbar spinal stenosis, and the main reason is that the pathological and physiological basis of secondary lumbar spinal stenosis can appear under the condition of nucleus pulposus protrusion; for those with congenital developmental spinal canal sagittal stenosis, herniated nucleus pulposus aggravates spinal canal stenosis, so that the symptoms are easily induced.
6. Muscle paralysis: paralysis is rarely caused by prolapse of lumbar intervertebral disc, but paralysis of the muscles is caused by radical damage. The muscle strength is weakened in the mild case and the muscle is disabled in the severe case. Clinically, foot drop is often caused by involvement of tibialis anterior, peroneal long short, extensor digitorum longus, and extensor longus, which are innervated by the lumbar 5 spine nerve, and then quadriceps femoris (lumbar 3-4 spine innervation) and gastrocnemius (sacral 1 spine innervation).
7. Cauda equina symptoms: it is mainly seen in the posteromedial and paraspinal herniation of nucleus pulposus, and therefore, it is clinically rare. It is mainly manifested as numbness and stabbing pain in perineum, dysuria and defecation, impotence (male), and sciatica in both lower extremities. The severe patients may have symptoms such as incontrollable defecation and incomplete paralysis of both lower limbs.
8. Lower abdominal pain or thigh front pain: in high lumbar disc herniation, pain occurs in the lower abdominal groin area or the anterior medial thigh area of the nerve root innervated area when the lumbar 2, 3, 4 nerve roots are involved. In addition, pain in the groin area or the front and medial thigh area may also occur in some patients with low lumbar disc herniation. For those with 3-4 lumbar disc herniation, 1/3 may have pain in the groin area or the inner front thigh. It occurs in a substantially equal rate in lumbar 4-5 and lumbar 5-sacral 1 space with herniated disc. This pain is usually referred to as pain.
9. And others: depending on the location and degree of compression of the spinal nerve root, the extent of involvement of adjacent tissues, and other factors, there may be some rare symptoms, such as hyperhidrosis, swelling, sacrococcygeal pain, and radiating pain in the knee.
Western medicines taken orally nowadays have certain damage to liver, kidney and stomach and intestine, and have great side effect. The existing traditional Chinese medicine formula is used for treatment, and the treatment effect is poor, the treatment time is too long, and the like. Therefore, the development of a novel traditional Chinese medicine composition for treating lumbar disc herniation and compression of sciatic nerve has urgent research value, good economic benefit and industrial application potential, and is the basis and the motivation for the completion of the invention.
Disclosure of Invention
The invention aims to solve the technical problem of overcoming the defects of the prior art and provides a traditional Chinese medicine composition for treating lumbar intervertebral disc protrusion.
In order to solve the technical problems, the technical scheme provided by the invention is as follows: a traditional Chinese medicine composition for treating lumbar intervertebral disc protrusion comprises the following components in parts by weight: 5-50 parts of ephedra, 3-10 parts of achyranthes, 3-10 parts of obscured homalomena rhizome, 3-10 parts of anisetree, 3-10 parts of pawpaw, 3-20 parts of frankincense, 3-20 parts of myrrh, 3-10 parts of divaricate saposhnikovia root, 3-10 parts of notopterygium root, 3-10 parts of eucommia charcoal, 3-20 parts of native copper, 3-10 parts of safflower, 3-10 parts of liquorice, 3-10 parts of cassia twig, 3-10 parts of Dahuo and 5-50 parts of prepared nux vomica.
Further, the traditional Chinese medicine composition comprises the following components in parts by weight: 20 parts of ephedra, 7 parts of achyranthes, 6 parts of homalomena occulta, 7 parts of anisetree, 6 parts of pawpaw, 12 parts of frankincense, 12 parts of myrrh, 6 parts of divaricate saposhnikovia root, 6 parts of notopterygium root, 7 parts of eucommia ulmoides charcoal, 11 parts of native copper, 6 parts of safflower, 7 parts of liquorice, 6 parts of cassia twig, 7 parts of radix angelicae gigantis and 30 parts of prepared nux vomica.
The preparation method of the traditional Chinese medicine composition comprises the following steps:
(1) taking a certain amount of nux vomica, stir-frying with sand, and then carrying out unhairing treatment, wherein the dosage of the formula is taken for later use;
(2) adding the rest formula medicines, uniformly mixing, crushing by a crusher, and sieving by a 100-mesh sieve;
(3) and preparing the honeyed pills with the diameter of 1 cm by a honeyed pill machine, and drying in the shade to obtain the finished product.
Furthermore, the sand-frying temperature in the step (1) is 180 ℃, the sand-frying time is 8 minutes, and the most preferable is that the sand-frying temperature is 180 ℃ and the sand-frying time is 8 minutes, the sand-frying time is scalded until the surface of the nux vomica swells, and the interior of the nux vomica turns brown and yellow slightly.
Further, the step (3) is to heat the honey at a high temperature.
Further, the pulverizer, the honeyed pill machine and the operation table in the steps (1) to (3) are strictly disinfected, and the whole manufacturing room is clean, tidy and sterile in environment.
The invention has the following advantages:
the invention aims to overcome the defect of the modern medicine in the treatment of the lumbar disc herniation compression sciatic nerve, and discloses the treatment of the lumbar disc herniation compression sciatic nerve, which comprises the following steps: has obvious curative effect, short treatment time, no relapse after healing, no toxic or side effect and the like.
The Chinese medicinal composition has the effects of warming kidney, tonifying yang, nourishing marrow and strengthening bones; breaking accumulation and dissipating blood stasis, and dispelling cold and removing dampness; relieving swelling, resolving hard mass, setting bone and stretching muscle; dredging meridian passage, strengthening waist and relieving pain. The clinical treatment of lumbar disc herniation, protrusion, prolapse and sciatica has obvious curative effect. It is also suitable for treating rheumatism osteopathia such as cervical syndrome, thoracic vertebra disease, acute and chronic lumbar sprain, spinal canal stenosis, hyperostosis, arthritis due to wind-cold dampness, proliferative arthritis, and old cold leg. For treating the lumbar intervertebral disc protrusion, the pain is relieved after the medicament is generally used for 1 to 5 days, the effect is shown after about 20 days, the pain is basically cured after 60 to 90 days, the disease is stable after 80 to 90 percent of patients stop taking the medicament for 150 days continuously, and the normal life and work can be recovered.
Detailed Description
The present invention will be described in further detail with reference to examples.
Example 1
The traditional Chinese medicine composition for treating the lumbar intervertebral disc protrusion is characterized by comprising the following components in parts by weight: 5 parts of ephedra, 3 parts of achyranthes, 3 parts of homalomena occulta, 3 parts of anisetree, 3 parts of pawpaw, 3 parts of frankincense, 3 parts of myrrh, 3 parts of divaricate saposhnikovia root, 3 parts of notopterygium root, 3 parts of eucommia ulmoides charcoal, 3 parts of native copper, 3 parts of safflower, 3 parts of liquorice, 3 parts of cassia twig, 3 parts of radix angelicae gigantis and 5 parts of prepared nux vomica.
Example 2
The traditional Chinese medicine composition for treating the lumbar intervertebral disc protrusion is characterized by comprising the following components in parts by weight: 50 parts of ephedra, 10 parts of achyranthes root, 10 parts of obscured homalomena rhizome, 10 parts of anisetree, 10 parts of pawpaw, 20 parts of frankincense, 20 parts of myrrh, 10 parts of divaricate saposhnikovia root, 10 parts of notopterygium root, 10 parts of eucommia bark charcoal, 20 parts of native copper, 10 parts of safflower, 10 parts of liquorice, 10 parts of cassia twig, 10 parts of Dahuo and 50 parts of prepared nux vomica.
Example 3
The traditional Chinese medicine composition for treating the lumbar intervertebral disc protrusion is characterized by comprising the following components in parts by weight: 28 parts of ephedra, 6 parts of achyranthes root, 7 parts of obscured homalomena rhizome, 6 parts of anisetree, 7 parts of pawpaw, 12 parts of frankincense, 11 parts of myrrh, 6 parts of divaricate saposhnikovia root, 6 parts of notopterygium root, 7 parts of eucommia bark charcoal, 12 parts of native copper, 6 parts of safflower, 7 parts of liquorice, 7 parts of cassia twig, 6 parts of Dahuo and 27 parts of prepared nux vomica.
The preparation method of the traditional Chinese medicine composition for treating the protrusion of the lumbar intervertebral disc comprises the following steps:
(1) taking a certain amount of nux vomica, stir-frying with sand, and then performing unhairing treatment, wherein the stir-frying temperature with sand is 180 ℃, the stir-frying time with sand is 8 minutes, and the dosage of the formula is taken for standby;
(2) adding the rest formula medicines, uniformly mixing, crushing by a crusher, and sieving by a 100-mesh sieve;
(3) and preparing honeyed pills with the diameter of 1 cm by a honeyed pill machine, heating the honeyed pills at high temperature, and drying in the shade to obtain the finished product.
Wherein the pulverizer, the honeyed pill machine and the operation table are strictly disinfected, and the whole production room has clean, tidy and sterile environment.
Among these, it is noted that: 1. patients with heart disease, hypertension, liver disease, diabetes, excessive heat, cold stage and excessive internal heat should not be used in principle, and they should be used with cautions, but under the guidance of physicians.
2. It is contraindicated for pregnant women and children.
3. It is contraindicated for patients who are using other drugs to treat diseases.
4. No drinking is prohibited.
5. Spicy and high calorie food is prohibited during administration.
6. No physician permits anyone to use without authorization.
7. The dosage is strictly administered and is not derived from the addition of the dosage.
8. And the device is strictly managed and cannot be placed in a place which can be taken by a child.
9. The medicine should not be taken in the day of bathing, and the medicine should not be taken in the day of taking.
10. The sitting, lying, standing and walking needs to be moderate, and the posture can be flexibly changed.
11. The physical exercise can be done in the right place, which is beneficial to rehabilitation.
12. Cold and damp proofing, and attention to waist warming.
13. The actions of lifting objects on one side, climbing stairs, sweeping and mopping the floor are avoided as much as possible.
14. Regular work and rest, scientific diet, full nutrition and benefit to accelerate recovery.
Typical cases of the invention:
1. chen, Man, 48 years old, Hebei province Cangzhou city Wuqiao county farmers. In 2002, patients with lumbar disc herniation and sciatica suffer from three-nerved spicebush, two-nerved spicebush and special hospitals are CT determined and take medicine, acupuncture, massage, small knife needle and physical therapy for nearly one year, and the curative effect is very little. The walking stick can also walk before and just after treatment for three months, then the walking stick is gradually aggravated in the treatment process, the walking stick starts to lean on a single crutch, the walking stick can walk intermittently in a slow step, and the walking stick can only take steps after pushing off the wall, so that the pain is as pain as knife cutting, and the emotion is very low. The traditional Chinese medicine composition is used for treating 7-month menstruation in 2002, pain is relieved on day 10, a user can lean on a crutch to get on the street on day 25, the user can directly go to an outpatient service after throwing off the crutch on day 40, the user can return home in a passenger car after the disease is cured on day 50, and the user can live as normal people in the same dry farming season on day 60. The medicine is stopped after 100 days, then the patient goes to Hebei province as a civil worker, and lifts the motor every day, and the lumbar disc herniation is not cured in 17 years.
2. Yang, male, 50 years old, Ningjin farmer, Texas, Shandong province. The patients with lumbar disc herniation, spinal stenosis, lumbar hyperosteogeny and sciatica have many years, CT diagnosis in the third hospital and various advanced treatment means used in various hospitals have no obvious curative effect, so that the patients gradually have difficulty in walking and basically lose the dry farming ability. When the traditional Chinese medicine composition is used in 2017 in 3 months, pain is obviously relieved on day 21, walking is advanced, the farm life of the field can be naturally achieved unconsciously on day 35, and the diagnosis of the patient is called as follows on day 60: the waist and legs are not painful, which is the same as the former times. "the medicine is stopped after the medicine is applied for 30 days, and the whole autumn harvest and agricultural activity is finished like the ordinary people, which is not done so far.
Although the invention has been described in detail hereinabove with respect to a general description and specific embodiments thereof, it will be apparent to those skilled in the art that modifications or improvements may be made thereto based on the invention. Accordingly, such modifications and improvements are intended to be within the scope of the invention as claimed.
Claims (6)
1. The traditional Chinese medicine composition for treating the lumbar intervertebral disc protrusion is characterized by comprising the following components in parts by weight: 5-50 parts of ephedra, 3-10 parts of achyranthes, 3-10 parts of obscured homalomena rhizome, 3-10 parts of anisetree, 3-10 parts of pawpaw, 3-20 parts of frankincense, 3-20 parts of myrrh, 3-10 parts of divaricate saposhnikovia root, 3-10 parts of notopterygium root, 3-10 parts of eucommia charcoal, 3-20 parts of native copper, 3-10 parts of safflower, 3-10 parts of liquorice, 3-10 parts of cassia twig, 3-10 parts of Dahuo and 5-50 parts of prepared nux vomica.
2. The traditional Chinese medicine composition for treating lumbar intervertebral disc protrusion according to claim 1, wherein the traditional Chinese medicine composition comprises the following components: the traditional Chinese medicine composition comprises the following components in parts by weight: 20 parts of ephedra, 7 parts of achyranthes, 6 parts of homalomena occulta, 7 parts of anisetree, 6 parts of pawpaw, 12 parts of frankincense, 12 parts of myrrh, 6 parts of divaricate saposhnikovia root, 6 parts of notopterygium root, 7 parts of eucommia ulmoides charcoal, 11 parts of native copper, 6 parts of safflower, 7 parts of liquorice, 6 parts of cassia twig, 7 parts of radix angelicae gigantis and 30 parts of prepared nux vomica.
3. The traditional Chinese medicine composition for treating lumbar intervertebral disc protrusion according to claim 1, wherein the preparation method of the traditional Chinese medicine composition comprises the following steps:
(1) taking a certain amount of nux vomica, stir-frying with sand, and then carrying out unhairing treatment, wherein the dosage of the formula is taken for later use;
(2) adding the rest formula medicines, uniformly mixing, crushing by a crusher, and sieving by a 100-mesh sieve;
(3) and preparing the honeyed pills with the diameter of 1 cm by a honeyed pill machine, and drying in the shade to obtain the finished product.
4. The traditional Chinese medicine composition for treating lumbar intervertebral disc protrusion according to claim 1, wherein the traditional Chinese medicine composition comprises the following components: in the step (1), the sand frying temperature is 180 ℃, and the sand frying time is 8 minutes.
5. The traditional Chinese medicine composition for treating lumbar intervertebral disc protrusion according to claim 1, wherein the traditional Chinese medicine composition comprises the following components: and (4) heating the honey at high temperature in the step (3).
6. The traditional Chinese medicine composition for treating lumbar intervertebral disc protrusion according to claim 1, wherein the traditional Chinese medicine composition comprises the following components: and (3) strictly sterilizing the pulverizer, the honeyed pill machine and the operating console in the steps (1) to (3), and ensuring that the whole manufacturing room is clean, tidy and aseptic in environment.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911217844.0A CN110693984A (en) | 2019-12-03 | 2019-12-03 | Traditional Chinese medicine composition for treating lumbar intervertebral disc protrusion |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911217844.0A CN110693984A (en) | 2019-12-03 | 2019-12-03 | Traditional Chinese medicine composition for treating lumbar intervertebral disc protrusion |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110693984A true CN110693984A (en) | 2020-01-17 |
Family
ID=69208055
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911217844.0A Pending CN110693984A (en) | 2019-12-03 | 2019-12-03 | Traditional Chinese medicine composition for treating lumbar intervertebral disc protrusion |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110693984A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112107640A (en) * | 2020-09-07 | 2020-12-22 | 杨博 | Externally applied medicine for dispelling wind and eliminating dampness and preparation method thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1144124A (en) * | 1996-03-07 | 1997-03-05 | 沈阳市骨科医院 | Sinew-soothing Network-Quickening Pill |
CN1368181A (en) * | 2001-01-31 | 2002-09-11 | 杨孟君 | Nano medicine 'Shufeng Dingtong' and its preparing process |
CN104107288A (en) * | 2013-04-20 | 2014-10-22 | 沈阳市骨科医院 | Sinew-relaxing collateral-activating pill |
-
2019
- 2019-12-03 CN CN201911217844.0A patent/CN110693984A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1144124A (en) * | 1996-03-07 | 1997-03-05 | 沈阳市骨科医院 | Sinew-soothing Network-Quickening Pill |
CN1368181A (en) * | 2001-01-31 | 2002-09-11 | 杨孟君 | Nano medicine 'Shufeng Dingtong' and its preparing process |
CN104107288A (en) * | 2013-04-20 | 2014-10-22 | 沈阳市骨科医院 | Sinew-relaxing collateral-activating pill |
Non-Patent Citations (1)
Title |
---|
王玉娟,等: "HPLC法同时测定追风舒经活血片中4种成分的含量", 《中国药房》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112107640A (en) * | 2020-09-07 | 2020-12-22 | 杨博 | Externally applied medicine for dispelling wind and eliminating dampness and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102600264B (en) | Externally-applied traditional Chinese medical composition for treatment of orthopedic diseases | |
CN102772619B (en) | Traditional Chinese medicine for treating bone impediment | |
CN102342983B (en) | Chinese medicinal composition for treating pain in the legs and numbness of the extremities and preparation method of preparation thereof | |
CN110693984A (en) | Traditional Chinese medicine composition for treating lumbar intervertebral disc protrusion | |
CN108310070B (en) | A Chinese medicinal composition for treating pain caused by hyperosteogeny of lumbar vertebra and cervical vertebra, and its preparation method | |
CN103751626B (en) | A kind of Chinese medicine preparation and preparation method for the treatment of sciatica | |
CN1391943A (en) | Chinese medicine paste for curing osteoarthropathy and preparing method | |
CN108186855B (en) | Mongolian medicine composition for treating lumbar intervertebral disc protrusion and preparation method thereof | |
CN102552843B (en) | Medicament composite for curing osteoarthropathy | |
CN105853969A (en) | Traditional Chinese medicine composition for treating lumbar disc herniation and lumbar spinal stenosis and preparation method thereof | |
CN104606313A (en) | Traditional Chinese medicinal ointment for treating osteoarticular diseases and bone fractures | |
CN111419924A (en) | A topical Chinese medicinal composition for treating various muscle and bone diseases, and its preparation device | |
CN105816619A (en) | Traditional Chinese medicine prescription capable of removing toxic substances and eliminating arthritis | |
CN110507796A (en) | A kind of Chinese medicine preparation for treating a variety of diseases | |
CN104147128A (en) | Traditional Chinese medicine preparation for treating refractory arthralgia | |
CN115645503B (en) | Medicinal composition and acupoint application paste for treating chronic pain diseases | |
CN117180357B (en) | External quick-release medicine for treating hyperosteogeny and preparation method thereof | |
CN109646657B (en) | Chinese herbal medicine decoction for treating spinal neuron neuritis | |
CN102614350A (en) | Chinese medicine for treating cervical spondylosis | |
CN108143799B (en) | Traditional Chinese medicine composition for treating brucellosis and preparation method thereof | |
CN106377615A (en) | Traditional Chinese medicine composition for treating lumbar hyperplasia, cervical hyperplasia and spurs | |
CN105560537A (en) | Medicine composition for treating osteoartritis and preparation method thereof | |
CN113456744A (en) | Traditional Chinese medicine composition, traditional Chinese medicine preparation and preparation method thereof | |
CN111529584A (en) | A Chinese medicinal composition for treating fracture, arthritis and acute and chronic soft tissue injury, and its preparation method | |
CN115607591A (en) | Traditional Chinese medicine composition for treating cervical vertebra/lumbar disc/rheumatic arthralgia and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200117 |
|
RJ01 | Rejection of invention patent application after publication |